Testosterone Replacement Therapy Can Slow COPD in Men
Posted: September 11, 2018
A new study shows that testosterone replacement therapy can help slow the progression of chronic obstructive pulmonary disease (COPD). Slated for publication in the journal Chronic Respiratory Disease, the study helped determine whether testosterone replacement therapy could reduce the risk of hospitalization due to respiratory disease for middle-aged and older men with COPD.
“Previous studies have suggested that testosterone replacement therapy may have a positive effect on lung function in men with COPD,” said the study’s author, Jacques Baillargeon, in a release. Baillargeon is a professor in preventive medicine and community health at University of Texas Medical Branch at Galveston.
Baillargeon and team examined data from 450 men ages 40-63 with COPD who began testosterone replacement therapy between 2005 and 2014. They also studied data from 253 men ages 66 and up with COPD who initiated testosterone replacement therapy between 2008 and 2013.
According to Baillargeon, middle-aged users of testosterone therapy had a 4.2 percent greater decrease in respiratory hospitalizations compared with non-users. Older testosterone replacement therapy users had a 9.1 percent greater decrease.
Read more in COPD News Today.
Disclaimer: This article is made available for general, entertainment and educational purposes only. The opinions expressed herein do not necessarily reflect those of Low T Center. You should always seek the advice of a licensed healthcare professional.